Monday's healthcare upgrades, downgrades, and initiations

|By:, SA News Editor

Jazz Pharmaceuticals (JAZZ -2%) cut to Neutral from Buy at Goldman. Price target is $123.

Aveo Pharmaceuticals (AVEO -3.5%) cut to Underperform from Sector Perform at RBC. Price target is $2.

Centene (CNC +1.5%) upgraded to Positive from Neutral at Susquehanna. Price target is $68.

St. Jude Medical (STJ +2.4%) upgraded to Outperform from Market Perform at BMO. Price target is $66.

Evogene (EVGN -3.4%) initiated at Outperform at Oppenheimer. Price target is $26.

Impax Labs (IPXL +0.9%started at Buy at Goldman. Price target is $29.